Kevin B. Kaiserman

Pediatric Endocrinology

1401 W Merced Ave Ste 101
West Covina, CA 91790

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Replacing or Supplementing Automated Insulin Delivery With Inhaled Insulin: A 90-Day Randomized Controlled Trial.

Replacing or Supplementing Automated Insulin Delivery With Inhaled Insulin: A 90-Day Randomized Controlled Trial.

Journal: Journal of diabetes science and technology

Published: November 11, 2025

Inhaled Insulin Dosing in a Randomized Trial in Adults With Type 1 Diabetes.

Inhaled Insulin Dosing in a Randomized Trial in Adults With Type 1 Diabetes.

Journal: AACE endocrinology and diabetes

Published: July 21, 2025

Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion.

Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: March 25, 2025

Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.

Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: October 02, 2023

Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.

Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor.

Journal: Diabetes technology & therapeutics

Published: May 30, 2023

Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.

Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.

Journal: Diabetes technology & therapeutics

Published: December 06, 2022

Time-Action Profile of Technosphere Insulin in Children with Type 1 Diabetes.

Time-Action Profile of Technosphere Insulin in Children with Type 1 Diabetes.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: October 20, 2022

Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage.

Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage.

Journal: Journal of diabetes science and technology

Published: July 14, 2022

Transforming Evidence Generation for Drug Label Changes: A Case Study.

Transforming Evidence Generation for Drug Label Changes: A Case Study.

Journal: Annals of biomedical engineering

Published: May 11, 2022

Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.

Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.

Journal: Diabetes technology & therapeutics

Published: March 09, 2022

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.

Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: October 25, 2021

Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial.

Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial.

Journal: Pediatric diabetes

Published: July 11, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026